← SynDRA
ROCURONIUM
SynDRA canonical compound SYN0023493 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CHRNA2 |
|---|
| Mechanism of action | Acetylcholine receptor antagonist |
|---|
| Indication | anesthetic |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- CHRNA2
- CHRM2
- CHRNA1
- CHRNB1
- CHRND
- CHRNG
- HTR3A
Mechanisms of action (all sources)
- Acetylcholine receptor antagonist
- CHRNA2 ANTAGONIST
- CHRNA1 ANTAGONIST
- CHRNB1 ANTAGONIST
- CHRND ANTAGONIST
Drug classes
- Neuromuscular Agents
- Neuromuscular Blocking Agents
- Neuromuscular Nondepolarizing Agents
- Peripheral Nervous System Agents
- Nondepolarizing Neuromuscular Blocker
ATC classes
- M03A · MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
Cross-references
Synonyms
- ORG 9426
- rocuronium bromide
- zemuron
- esmeron
- Rocuronium cation
- Rocuronium ion
- Esmeron (TN)
- Zemuron (TN)
- (2beta,3alpha,5alpha,16beta,17beta)-17-acetoxy-16-(1-allylpyrrolidinium-1-yl)-3-hydroxy-2-(morpholin-4-yl)androstane
- [(2S,3S,5S,8R,9S,10S,13S,14S,16S,17R)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-16-(1-prop-2-enylpyrrolidin-1-ium-1-yl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
- rocuronium-bromide
- WRE554RFEZ
- CHEBI:8884
- Esmerone
- RefChem:56463
- DTXCID1028314
- Zemuron
- UNII-WRE554RFEZ
- NCGC00167433-01
- RBr
- ROCURONIUM [MI]
- Epitope ID:174837
- C07556
- ROCURONIUM [WHO-DD]
- SCHEMBL29958
- BIDD:GT0360
- GTPL4003
- orb1708656
- TQP0579
- YXRDKMPIGHSVRX-OOJCLDBCSA-N
- HMS2090E03
- BDBM50248153
- AKOS040736692
- CS-0733
- NCGC00167433-04
- NCGC00167433-05
- DA-67272
- HY-17033
Reported adverse events
Look up ROCURONIUM in the interactive SynDRA portal →